Redirect Notice

Looks like you clickedhttps://www.streetinsider.com/Corporate+News/Progenics+Pharma+%28PGNX%29+Advances+1095+into+Phase+2+Clinical+Development+Following+Discussions+with+the+FDA/14698307.html

If you do not want to visit that page, you can close this browser tab.